Results 21 to 30 of about 18,738 (216)

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection

BMC Cancer, 2017
Background UroVysion fluorescence in situ hybridization (uFISH) was reported to have superior sensitivity to urine cytology. However uFISH studies are limited by varying definitions of what is considered a positive result, absence of histopathology and ...
Hugh J. Lavery, Boriana Zaharieva, Andrew McFaddin, Nyla Heerema, Kamal S. Pohar   +4 more
doaj   +1 more source

Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer

Pharmaceutics, 2022
Muscle Invasive Bladder Cancer (MIBC) is a subset of bladder cancer with a significant risk for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses.
Jillian Marie Walker, Padraic O’Malley, Mei He   +2 more
doaj   +1 more source

Urine cytology: Updates and challenges in reporting systems, ancillary studies, and artificial intelligence

Human Pathology Reports
Several urine cytology classifications have been published in the literature. However, global acceptance in the field of urine cytology was only gained in 2016 after The Paris System for reporting urinary cytology was published. Despite this Paris System
Juan Xing, Jordan P. Reynolds, Xiaoying Liu, Liron Pantanowitz   +3 more
doaj   +1 more source

Significance of Suspicious Urine Cytology (Class III) in Diagnostic Cystoscopy Follow-up of Bladder Cancer

Forbes Tıp Dergisi
Objective: The aim of this study was to determine the appropriate path to follow in the cystoscopic follow-up of patients with suspicious urine cytology but negative malignancy findings on cystoscopy.
Yunus Erol BOZKURT, Ali Can ALBAZ, Anıl GENÇOĞLU, Talha MÜEZZİNOĞLU   +3 more
doaj   +1 more source

The influence of urine cytology on our practice

Urology Annals, 2012
Objective: Bladder cancer is a common malignancy. It is ranked ninth among male population in Saudi Arabia. Urine cytology is used by some physicians routinely in the workup for diagnosis and follow-up of patients with urothelial cancer. Our objective is
Mahmoud Alameddine, Anmar Nassir
doaj   +1 more source

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer

Cancer Medicine, 2023
Background To evaluate whether urine laminin‐γ2 monomer (Ln‐γ2m) offers a useful biomarker for patients with non‐muscle‐invasive bladder cancer (NMIBC).
Takashi Karashima, Susumu Umemoto, Takeshi Kishida, Kimito Osaka, Masatoshi Nakagawa, Eisaku Yoshida, Toru Yoshimura, Masahiko Sakaguchi, Hiroyuki Nishimoto, Mami Tai, Keiji Inoue, Motoharu Seiki, Naohiko Koshikawa, Taro Shuin   +13 more
doaj   +1 more source

Diagnosis of fusariosis in urine cytology [PDF]

Journal of Clinical Pathology, 2006
Fusarium is a filamentous fungus widely distributed in plants and in the soil. Most species are more common at tropical and subtropical areas. Besides being a common contaminant and a well-known plant pathogen, Fusarium sp may cause various infections in humans.
Cheng-Chuan, Su, Hui-Jine, Hsu, Jiunn-Jong, Wu, Chien-Wen, Chou   +3 more
openaire   +2 more sources

How Accurate is Urine Cytology? [PDF]

Journal of the Royal Society of Medicine, 1986
Exfoliative urinary cytology was performed on 260 new cases of histologically proven urothelial cancer. The site, size, shape and histological grade of the tumours were documented, and they were classified by the TNM system. Overall, urine cytology was positive in 135 (52%), suspicious in 28 (11%) and negative in 97 (38%) cases.
M, Curling, G, Broome, W F, Hendry
openaire   +2 more sources

Effectiveness of bladder tumor antigen quantitative test in the diagnosis of bladder carcinoma in a schistosoma endemic area

Urology Annals, 2019
Introduction: Bladder carcinoma is the most common male cancer in our environment due to endemicity of schistosomiasis. Squamous-cell carcinoma is the most common histological type and patients present at an advanced stage. The objective of this study is
Abubakar Sadiq Muhammad, Ismaila Arzika Mungadi, Nnaemeka Ndodo Darlington, Garba Diffa Kalayi   +3 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source